PMCB News and Press, PharmaCyte Biotech Inc. From 07/22/19

PMCB - PharmaCyte Biotech and UTS Creating Advanced Version of Melligen Cells to Treat Diabetes

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , today announced it has entered into a new research agreement with t...

PMCB - PharmaCyte Biotech Appoints Cellular Expert to Medical and Scientific Advisory Board

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , today announced that it has appointed David A. Judd to Ph...

PMCB - 'Historic' reform hearing on marijuana

U.S. lawmakers weighed reforming pot laws in what advocates called a "historic” hearing on Wednesday, though there didn't appear to be a clear consensus approach, such as giving states the right for legalization, removing weed from schedule 1 of the Controlled Substances Act, or pro...

PMCB - PharmaCyte Biotech Releases New Interviews from Austrianova's GMP Facility on Company's Website

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , today announced that its Chief Executive Officer, Kenneth...

PMCB - PharmaCyte Biotech CEO in Thailand to Oversee Production of Final Clinical Trial Material for IND Submission

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , today announced that its Chief Executive Officer, Kennet...

PMCB - PharmaCyte Biotech CEO Visiting GMP Facility with Cellular Biology Consultant During Production of Pancreatic Cancer Product

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , today announced that its Chief Executive Officer, Kennet...

PMCB - PharmaCyte Biotech Proceeding with GMP Production of Pancreatic Cancer Product After Successful Changes to Manufacturing Process

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , today announced that it has made further important progr...

PMCB - PharmaCyte Biotech Bioengineers Cell Line for Cannabis Program to Treat Cancers

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , today announced that its research partner, the University of Northern C...

PMCB - PharmaCyte Biotech Advances Manufacturing Process for Clinical Trial in Pancreatic Cancer

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , today announced that advances have been completed in the manufacturing ...

PMCB - How does teen smoking risks affect pot stocks?

Researchers have found that cannabis use during the teenage years was associated with a nearly 40% bump in the risk of depression and a 50% increase in the risk of suicidal thoughts in adulthood, according to a study published in JAMA Psychiatry. More news on: Tilray, Inc., Cronos Group,...

Company Name:	PharmaCyte Biotech Inc.
Stock Symbol:	PMCB
Market:	OTC
Website:	pharmacyte.com